Literature DB >> 21221981

Pregnancy after breast cancer: case report and review of the literature.

Barbara Lawrenz1, Malgorzata Banys, Melanie Henes, Eva Neunhoeffer, Eva-Maria Grischke, Tanja Fehm.   

Abstract

Despite breast cancer diagnosis and treatment, women of childbearing age often desire a pregnancy. Since the average age of women giving birth for the first time is increasing, many young patients diagnosed with breast cancer have not started or completed their family planning. Thus, gynecologists and oncologists are confronted more often with the question of childbearing after breast cancer. Current data from retrospective trials do not suggest an increased risk of a recurrence or progress of the disease associated with pregnancy after stage-adjusted treatment. Also, the risk of fetal malformations and damage to the fetus after chemotherapy and/or hormone therapy seems similar to that in the general population. Women who receive chemotherapy are advised to wait at least 6 months before they attempt to conceive. The question whether to become pregnant must be discussed individually with the patient, based on tumor characteristics, stage of the disease and patient's wishes.

Entities:  

Mesh:

Year:  2011        PMID: 21221981     DOI: 10.1007/s00404-010-1829-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Pregnancy despite ovarian insufficiency in a patient with breast cancer.

Authors:  Erica B Mahany; Dawn L Hershman; Mark V Sauer; Janet M Choi
Journal:  Reprod Med Biol       Date:  2012-07-19

Review 2.  Childbearing attitudes and decisions of young breast cancer survivors: a systematic review.

Authors:  Vânia Gonçalves; Ivana Sehovic; Gwendolyn Quinn
Journal:  Hum Reprod Update       Date:  2013-09-27       Impact factor: 15.610

3.  Extended adverse effects of cyclophosphamide on mouse ovarian function.

Authors:  Jihyun Kim; Sooseong You
Journal:  BMC Pharmacol Toxicol       Date:  2021-01-07       Impact factor: 2.483

4.  Samul-tang ameliorates oocyte damage due to cyclophosphamide-induced chronic ovarian dysfunction in mice.

Authors:  Jihyun Kim; Sooseong You
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

Review 5.  Breast cancer in young women: special considerations in multidisciplinary care.

Authors:  Chantal Reyna; Marie Catherine Lee
Journal:  J Multidiscip Healthc       Date:  2014-09-29

6.  Matching methods to create paired survival data based on an exposure occurring over time: a simulation study with application to breast cancer.

Authors:  Alexia Savignoni; Caroline Giard; Pascale Tubert-Bitter; Yann De Rycke
Journal:  BMC Med Res Methodol       Date:  2014-06-26       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.